Targeted Oncology3h
Exploring Zoldonrasib, Pan-RAS Inhibitors, and Future KRAS Therapies
Alexander I. Spira, MD, PhD, FACP, discusses the next steps in the clinical development of zoldonrasib for patients with KRAS ...
Biotech Alert: Searches spiking for these stocks today
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
Elicio Therapeutics secures $10 million in direct offering
BOSTON - Elicio Therapeutics , Inc. (NASDAQ:ELTX), a clinical-stage biotech company focusing on cancer immunotherapies, has ...
Edible Garden Continues to Lead Sustainable Agriculture with Strong 2024 Results in Walmart’s Project Gigaton
Project Gigaton Impact Edible Garden’s 2024 Project Gigaton Impact Advanced Technologies and Strategic Partnerships ...
HOOKIPA Pharma Inc.: HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV
HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of a curative regimen for human immunodeficiency virus (HI ...
Cogent Biosciences to Participate in the Guggenheim Biotech Conference
WALTHAM, Mass. and BOULDER, Colo., Jan. 30, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: COGT), a biotechnology company focused on ...
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV
HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of ...
NexGen Commences Expanded 43,000 Meter Drill Program at Patterson Corridor East
CNW/ - NexGen Energy Ltd. ("NexGen" or the "Company") (TSX: NXE) (NYSE: NXE) (ASX: NXG) is excited to announce the ...